Bioresorbable Polymers Market – Global Forecast To 2029
In terms of value, the bioresorbable polymers market is estimated to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6%. Favorable regulations and policies by the government towards healthcare industry are positively influencing the bioresorbable polymers market.
生体吸収性ポリマー市場は、2024 年の 5 億米ドルから 2029 年までに 8 億 6,720 万米ドルに、CAGR 11.6% で成長すると推定されています。医療業界に対する政府による有利な規制と政策は、生体吸収性ポリマー市場にプラスの影響を与えています。

The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on bioresorbable polymers offered by top players in the global market
- Analysis of key drivers: (Increasing number of surgical interventions, Boost in demand of biocompatible medical devices, Growing demand in drug delivery application, Favorable reimbursement scenario), opportunities (Electrospinning and 3D Printing Technologies), and challenges (Stringent regulatory framework for medical devices)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioresorbable polymers market
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for bioresorbable polymers across regions.
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global bioresorbable polymers market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the bioresorbable polymers market